ResearcherYamaguchi UniversityNo recent work listed
Byron Baron
Matched on ORCID iD 0000-0001-5722-6295; OpenAlex author ID A5033744969. Sources: OpenAlex.
Their work
- Papers
- 14 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2013: 1 paper · 2014: 2 papers · 2015: 6 papers · 2016: none · 2017: 1 paper · 2018: 2 papers · 2019: none · 2020: none · 2021: 2 papers
Papers 14
- ITGA2, LAMB3, and LAMC2 may be the potential therapeutic targets in pancreatic ductal adenocarcinoma: an integrated bioinformatics analysis. Co-author DOI 10.1038/s41598-021-90077-x↗
- A standardized extract of cultured Lentinula edodes mycelia downregulates cortactin in gemcitabine-resistant pancreatic cancer cells. Co-author DOI 10.3892/ol.2021.12915↗
- CUB Domain-containing Protein 1 (CDCP1) Is Down-regulated by Active Hexose-correlated Compound in Human Pancreatic Cancer Cells. Co-author DOI 10.21873/anticanres.12961↗
- Enzyme-treated Asparagus Extract Down-regulates Heat Shock Protein 27 of Pancreatic Cancer Cells. Co-author DOI 10.21873/invivo.11305↗
- PI3K inhibitor LY294002, as opposed to wortmannin, enhances AKT phosphorylation in gemcitabine-resistant pancreatic cancer cells. Co-author DOI 10.3892/ijo.2016.3804↗
- The Histone Deacetylase Inhibitor Valproic Acid Sensitizes Gemcitabine-Induced Cytotoxicity in Gemcitabine-Resistant Pancreatic Cancer Cells Possibly Through I… Co-author DOI 10.1007/s11523-015-0370-0↗
- Cofilin-phosphatase slingshot-1L (SSH1L) is over-expressed in pancreatic cancer (PC) and contributes to tumor cell migration. Co-author DOI 10.1016/j.canlet.2015.02.015↗
- Isolation of a growth factor stress-induced pancreatic cancer sub-population: insight into changes due to micro-environment. Co-author PMID 25770187↗
- Comparative proteomic analysis of two stress-management strategies in pancreatic cancer. Co-author PMID 25770192↗
- Resistance to gemcitabine in the pancreatic cancer cell line KLM1-R reversed by metformin action. Co-author PMID 25862846↗
- Active Hexose-correlated Compound Down-regulates Heat Shock Factor 1, a Transcription Factor for HSP27, in Gemcitabine-resistant Human Pancreatic Cancer Cells. First author PMID 26504030↗
- Gemcitabine induces poly (ADP-ribose) polymerase-1 (PARP-1) degradation through autophagy in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0109076↗
- Active hexose-correlated compound down-regulates sex-determining region Y-box 2 of pancreatic cancer cells. Co-author PMID 25202061↗
- Human pancreatic cancer cells with acquired gemcitabine resistance exhibit significant up-regulation of peroxiredoxin-2 compared to sensitive parental cells. Co-author PMID 24222118↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yasuhiro Kuramitsu · 14 shared papers, 2013–2021 · strength 1.00
- Paper ITGA2, LAMB3, and LAMC2 may be the potential therapeutic targets in pancreatic ductal adenocarcinoma: an integrated bio… DOI 10.1038/s41598-021-90077-x↗
- Paper A standardized extract of cultured Lentinula edodes mycelia downregulates cortactin in gemcitabine-resistant pancreatic… DOI 10.3892/ol.2021.12915↗
- Paper Enzyme-treated Asparagus Extract Down-regulates Heat Shock Protein 27 of Pancreatic Cancer Cells. DOI 10.21873/invivo.11305↗
- Kazuyuki Nakamura · 9 shared papers, 2013–2017 · strength 0.48
- Paper Isolation of a growth factor stress-induced pancreatic cancer sub-population: insight into changes due to micro-environ… PMID 25770187↗
- Paper PI3K inhibitor LY294002, as opposed to wortmannin, enhances AKT phosphorylation in gemcitabine-resistant pancreatic can… DOI 10.3892/ijo.2016.3804↗
- Paper Resistance to gemcitabine in the pancreatic cancer cell line KLM1-R reversed by metformin action. PMID 25862846↗
- Yufeng Wang · 7 shared papers, 2013–2017 · strength 0.35
- Paper PI3K inhibitor LY294002, as opposed to wortmannin, enhances AKT phosphorylation in gemcitabine-resistant pancreatic can… DOI 10.3892/ijo.2016.3804↗
- Paper Resistance to gemcitabine in the pancreatic cancer cell line KLM1-R reversed by metformin action. PMID 25862846↗
- Paper The Histone Deacetylase Inhibitor Valproic Acid Sensitizes Gemcitabine-Induced Cytotoxicity in Gemcitabine-Resistant Pa… DOI 10.1007/s11523-015-0370-0↗
- Yoshihiko Maehara · 7 shared papers, 2013–2017 · strength 0.35
- Paper PI3K inhibitor LY294002, as opposed to wortmannin, enhances AKT phosphorylation in gemcitabine-resistant pancreatic can… DOI 10.3892/ijo.2016.3804↗
- Paper Resistance to gemcitabine in the pancreatic cancer cell line KLM1-R reversed by metformin action. PMID 25862846↗
- Paper Comparative proteomic analysis of two stress-management strategies in pancreatic cancer. PMID 25770192↗
- Shajedul Islam · 2 shared papers, 2021 · strength 0.30
- Paper ITGA2, LAMB3, and LAMC2 may be the potential therapeutic targets in pancreatic ductal adenocarcinoma: an integrated bio… DOI 10.1038/s41598-021-90077-x↗
- Paper A standardized extract of cultured Lentinula edodes mycelia downregulates cortactin in gemcitabine-resistant pancreatic… DOI 10.3892/ol.2021.12915↗
- Keisuke Kuhara · 2 shared papers, 2018–2021 · strength 0.21
- Paper A standardized extract of cultured Lentinula edodes mycelia downregulates cortactin in gemcitabine-resistant pancreatic… DOI 10.3892/ol.2021.12915↗
- Paper CUB Domain-containing Protein 1 (CDCP1) Is Down-regulated by Active Hexose-correlated Compound in Human Pancreatic Canc… DOI 10.21873/anticanres.12961↗
- Yoshihiro Abiko · 1 shared paper, 2021 · strength 0.16
- Masayuki Tokunaga · 2 shared papers, 2015–2018 · strength 0.13
- Takuya Shimada · 1 shared paper, 2018 · strength 0.10
- Isao Sakaida · 2 shared papers, 2013–2014 · strength 0.07
- Shigeyuki Suenaga · 2 shared papers, 2013–2014 · strength 0.07
- Masaru Terasaki · 1 shared paper, 2018 · strength 0.07
- Masaaki Oka · 1 shared paper, 2015 · strength 0.05
- Junya Nawata · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.